# BOSTON SCIENTIFIC CORP

> Cross-vertical US regulatory timeline. Last 180 days. 67 events.

**Ticker:** BSX · **SEC CIK:** 0000885725

## Vertical activity

| Vertical | Event count |
|---|---:|
| sec | 33 |
| fda | 20 |
| court | 8 |
| clinical | 6 |

## Timeline (newest first)

- **2026-11-20** `sec.filing` — 8-K — BOSTON SCIENTIFIC CORP — 2026-11-20 [importance=35]
- **2026-11-19** `sec.filing` — 424B5 — BOSTON SCIENTIFIC CORP — 2026-11-19 [importance=30]
- **2026-11-19** `sec.filing` — FWP — BOSTON SCIENTIFIC CORP — 2026-11-19 [importance=30]
- **2026-11-17** `sec.filing` — 8-K — BOSTON SCIENTIFIC CORP — 2026-11-17 [importance=35]
- **2026-11-09** `clinical.trial` — Boston Scientific Corporation — [The Evaluation of User Experience With FARAVIEW™ Technology of the OPAL HDx™ Mapping System When Used With the FARAWAVE ](https://api.morvs.ai/clinical/NCT07925359) [importance=25]
- **2026-11-04** `sec.insider.g` — Mahoney Michael F — Chairman, President & CEO [importance=15]
- **2026-11-04** `sec.insider.g` — Mahoney Michael F — Chairman, President & CEO [importance=15]
- **2026-11-02** `sec.filing` — 10-Q — BOSTON SCIENTIFIC CORP — 2026-11-02 [importance=45]
- **2026-11-01** `sec.insider.f` — O'Sullivan Miriam — SVP, Chief HR Officer [importance=15]
- **2026-11-01** `sec.insider.m` — O'Sullivan Miriam — SVP, Chief HR Officer [importance=15]
- **2026-10-28** `sec.filing` — 8-K — BOSTON SCIENTIFIC CORP — 2026-10-28 [importance=35]
- **2026-10-23** `court.docket` — cacd — Williams v. Boston Scientific Corporation [importance=45]
- **2026-10-22** `court.docket` — cacd — Rogers v. Boston Scientific Corporation [importance=45]
- **2026-10-20** `court.docket` — cacd — Albright v. Boston Scientific Corporation [importance=45]
- **2026-10-20** `court.docket` — cacd — Bayhi v. Boston Scientific Corporation [importance=45]
- **2026-10-20** `court.docket` — cacd — Lamy v. Boston Scientific Corporation [importance=45]
- **2026-10-20** `court.docket` — cacd — Robinette v. Boston Scientific Corporation [importance=45]
- **2026-10-16** `court.docket` — txsd — James v. Boston Scientific Corporation [importance=45]
- **2026-10-14** `court.docket` — cacd — Cooper v. Boston Scientific Corporation [importance=45]
- **2026-10-09** `clinical.trial` — Boston Scientific Corporation — [An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GB](https://api.morvs.ai/clinical/NCT07867886) [importance=25]
- **2026-10-07** `sec.filing` — 8-K — BOSTON SCIENTIFIC CORP — 2026-10-07 [importance=35]
- **2026-10-01** `clinical.trial` — Boston Scientific Corporation — [A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning.](https://api.morvs.ai/clinical/NCT07669727) [importance=25]
- **2026-09-28** `clinical.trial` — Boston Scientific Corporation — [A Global Randomized Trial Evaluating the FARAFLEX™ Mapping and Pulsed Field Ablation System With Electrographic Flow Map](https://api.morvs.ai/clinical/NCT07820930) [importance=25]
- **2026-09-24** `clinical.trial` — Boston Scientific Corporation — [Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)](https://api.morvs.ai/clinical/NCT07639684) [importance=25]
- **2026-09-23** `sec.filing` — 8-K — BOSTON SCIENTIFIC CORP — 2026-09-23 [importance=35]
- **2026-09-18** `clinical.trial` — Boston Scientific Corporation — [Study of Eso-SPONGE for Treating Leaks After Upper Gastrointestinal Surgery](https://api.morvs.ai/clinical/NCT07711093) [importance=25]
- **2026-09-10** `fda.recall` — Boston Scientific Corporation — [Class II](https://api.morvs.ai/recall/Z-0143-2027) [importance=60]
- **2026-09-08** `sec.filing` — 8-K — BOSTON SCIENTIFIC CORP — 2026-09-08 [importance=35]
- **2026-09-02** `sec.insider.f` — O'Connor Padraig Andrew — EVP, Global Operations [importance=15]
- **2026-09-02** `sec.insider.m` — O'Connor Padraig Andrew — EVP, Global Operations [importance=15]
- **2026-08-26** `sec.filing` — 8-K — BOSTON SCIENTIFIC CORP — 2026-08-26 [importance=35]
- **2026-08-25** `sec.insider.p` — Morano Susan E [importance=50]
- **2026-08-24** `fda.recall` — Boston Scientific Corporation — [Class I](https://api.morvs.ai/recall/Z-3214-2026) [importance=100]
- **2026-08-11** `sec.insider.i` — Woodworth Emily — SVP, Global Controller and CAO [importance=15]
- **2026-08-10** `sec.insider.i` — Monson Jonathan — EVP and CFO [importance=15]
- **2026-08-06** `fda.recall` — Boston Scientific Corporation — [Class II](https://api.morvs.ai/recall/Z-3081-2026) [importance=60]
- **2026-08-06** `fda.recall` — Boston Scientific Corporation — [Class II](https://api.morvs.ai/recall/Z-3083-2026) [importance=60]
- **2026-08-06** `fda.recall` — Boston Scientific Corporation — [Class II](https://api.morvs.ai/recall/Z-3082-2026) [importance=60]
- **2026-08-05** `sec.insider.p` — Habiger David C [importance=50]
- **2026-08-04** `sec.insider.p` — Habiger David C [importance=50]
- **2026-08-03** `sec.insider.p` — Mahoney Michael F — Chairman, President & CEO [importance=59]
- **2026-08-03** `sec.insider.p` — Habiger David C [importance=50]
- **2026-08-03** `sec.filing` — 10-Q — BOSTON SCIENTIFIC CORP — 2026-08-03 [importance=45]
- **2026-08-03** `sec.insider.i` — Mahoney Michael F — Chairman, President & CEO [importance=16]
- **2026-07-31** `sec.insider.p` — LUDWIG EDWARD J [importance=50]
- **2026-07-31** `sec.insider.i` — Fitzgerald Joseph Michael — EVP & Group Pres, Cardiology [importance=18]
- **2026-07-29** `sec.filing` — 8-K — BOSTON SCIENTIFIC CORP — 2026-07-29 [importance=35]
- **2026-07-27** `sec.filing` — 8-K — BOSTON SCIENTIFIC CORP — 2026-07-27 [importance=35]
- **2026-07-22** `fda.recall` — Boston Scientific Corporation — [Class II](https://api.morvs.ai/recall/Z-3188-2026) [importance=60]
- **2026-07-14** `fda.recall` — Boston Scientific Corporation — [Class II](https://api.morvs.ai/recall/Z-2961-2026) [importance=60]

## Provenance

This timeline merges events from these primary sources:

- **SEC EDGAR** — https://www.sec.gov/edgar (filings, insider transactions, Form 144, Schedule 13D/G)
- **openFDA** — https://api.fda.gov/ (recalls, drug labels)
- **USAspending** — https://api.usaspending.gov/ (federal contracts)
- **CourtListener** — https://www.courtlistener.com/ (federal court dockets)
- **CFPB** — https://www.consumerfinance.gov/data-research/consumer-complaints/ (consumer complaints)
- **NIH RePORTER** — https://api.reporter.nih.gov/ (grants)
- **Federal Reserve** — https://www.federalreserve.gov/supervisionreg/enforcementactions.htm (banking enforcement)
- **NHTSA** — https://api.nhtsa.gov/ (vehicle recalls)
- **DOJ** — https://www.justice.gov/news (press releases)
- **EPA ECHO** — https://echo.epa.gov/ (regulated facilities)
- **ClinicalTrials.gov** — https://clinicaltrials.gov/ (drug trials)
- **Senate LDA** — https://lda.senate.gov/ (lobbying disclosures)
- **OFAC** — https://sanctionslistservice.ofac.treas.gov/ (sanctions)

## Citation

> MORVS. Cross-vertical regulatory timeline for BOSTON SCIENTIFIC CORP. Retrieved 2026-11-22T12:36:53.322Z from https://api.morvs.ai/entity/BSX. Source terms: https://api.morvs.ai/license.

## Related

- [JSON timeline](https://api.morvs.ai/api/v1/entity/BSX/timeline?days=180)
- [Material events only](https://api.morvs.ai/api/v1/entity/BSX/material-events?days=180)
- [Compliance screen](https://api.morvs.ai/api/v1/screening/all?name=BOSTON%20SCIENTIFIC%20CORP)
- [All cross-vertical entities](https://api.morvs.ai/entity/)
- [Dataset catalog](https://api.morvs.ai/datasets/)

---

*MORVS · [Source-specific license and terms](https://api.morvs.ai/license) · Free or keyless access does not alter source terms.*
